behring coagulation timer bct (Dade Behring)
90
Structured Review
Dade Behring
behring coagulation timer bct
Behring Coagulation Timer Bct, supplied by Dade Behring, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/behring+coagulation+timer+bct/behring+coagulation+timer/pm36428852-61-45-49
Average 90 stars, based on 1 article reviews
Behring Coagulation Timer Bct, supplied by Dade Behring, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/behring+coagulation+timer+bct/behring+coagulation+timer/pm36428852-61-45-49
Average 90 stars, based on 1 article reviews
behring coagulation timer bct - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Clinical Proteomics:Article Title: Platelet factor V levels in moderate to severe congenital factor V deficiency. Article Snippet: two computer-based algorithms.. The variant Gly2043Val is predicted to probably impair the protein structure/function with a score of 0.04 (SIFT) and 2.138 (Polyphen), both scores being outside the normal values.. Indeed, the substitution Gly > Val at the corresponding position of FVIII protein have been reported to cause severe haemophilia A, whereas in the asymptomatic father of the proband, this mutation was associated with a FV activity of 64% [7]. Article Title: High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis Article Snippet: .. The activities of coagulation factor II (FII:c), factor V (FV:c), and factor VIII (FVIII:c) in COVID-19 patients were measured on an ACL TOP 750 analyzer (Instrumentation Laboratory, Werfen), while in non-COVID-19 subjects from VHS the same parameters were assayed with a similar method on a Article Title: Coinheritance of three novel FV gene mutations in a patient with a severe FV deficiency. Article Snippet: V. BAFUNNO,* G. FAVUZZI , T. FIERRO, M. CHETTA,* E. MASTRODICASA,§ E. CHINNI, E. GRANDONE, M. MARGAGLIONE* and P. GRESELE *Medical Genetics, Department of Biomedical Sciences, University of Foggia, Foggia; Atherosclerosis and Thrombosis Unit, Research Department, Istituto di Ricovero e Cura a Carattere Scientifico, Casa Sollievo della Sofferenza, S. Giovanni Rotondo, Foggia; Department of Internal Medicine, Section of Internal and Cardiovascular Medicine, University of Perugia, Perugia; and §Pediatric Onco-Hematology, S. Maria della Misericordia Hospital, Perugia, Italy Article Title: Prothrombin complex concentrate (Beriplex P/N) for control of bleeding after kidney trauma in a rabbit dilutional coagulopathy model. Article Snippet: Abbreviations: CI, 95% confidence interval; FII, factor FX, factor X; HES, hydroxyethyl starch; IQR, interqua complex concentrate; PT, prothrombin time; rFVIIa, rec ☆ Presented in part at the 53rd Annual Meeting of th Hemostasis Research, Vienna, Austria, February 4-7, 200 ⁎ Corresponding author.. Senior Director of Preclinica CSL Behring GmbH, Emil von Behring-Straße 76, D-3504 6421 39 2306; fax: +49 6421 39 5310.. E-mail address: gerhard.dickneite@cslbehring.com ( Article Title: Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele Article Snippet: .. FII:c, FV:c, and FVIII:c were measured on a Article Title: High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis. Article Snippet: .. The activities of coagulation factor II (FII:c), factor V (FV:c), and factor VIII (FVIII:c) in COVID-19 patients were measured on an ACL TOP 750 analyzer (Instrumentation Laboratory, Werfen), while in non-COVID-19 subjects from VHS the same parameters were assayed with a similar method on a Activity Assay:Article Title: Platelet factor V levels in moderate to severe congenital factor V deficiency. Article Snippet: two computer-based algorithms.. The variant Gly2043Val is predicted to probably impair the protein structure/function with a score of 0.04 (SIFT) and 2.138 (Polyphen), both scores being outside the normal values.. Indeed, the substitution Gly > Val at the corresponding position of FVIII protein have been reported to cause severe haemophilia A, whereas in the asymptomatic father of the proband, this mutation was associated with a FV activity of 64% [7]. Article Title: Coinheritance of three novel FV gene mutations in a patient with a severe FV deficiency. Article Snippet: V. BAFUNNO,* G. FAVUZZI , T. FIERRO, M. CHETTA,* E. MASTRODICASA,§ E. CHINNI, E. GRANDONE, M. MARGAGLIONE* and P. GRESELE *Medical Genetics, Department of Biomedical Sciences, University of Foggia, Foggia; Atherosclerosis and Thrombosis Unit, Research Department, Istituto di Ricovero e Cura a Carattere Scientifico, Casa Sollievo della Sofferenza, S. Giovanni Rotondo, Foggia; Department of Internal Medicine, Section of Internal and Cardiovascular Medicine, University of Perugia, Perugia; and §Pediatric Onco-Hematology, S. Maria della Misericordia Hospital, Perugia, Italy Coagulation:Article Title: Platelet factor V levels in moderate to severe congenital factor V deficiency. Article Snippet: two computer-based algorithms.. The variant Gly2043Val is predicted to probably impair the protein structure/function with a score of 0.04 (SIFT) and 2.138 (Polyphen), both scores being outside the normal values.. Indeed, the substitution Gly > Val at the corresponding position of FVIII protein have been reported to cause severe haemophilia A, whereas in the asymptomatic father of the proband, this mutation was associated with a FV activity of 64% [7]. Article Title: 3,4-Dihydro-2H-1,4-benzoxazine derivatives combining thrombin inhibitory and glycoprotein IIb/IIIa receptor antagonistic activity as a novel class of antithrombotic compounds with dual function. Article Snippet: 3,4-Dihydro-2H-1,4-benzoxazine derivatives possessing both thrombin inhibitory and glycoprotein IIb/IIIa (GPIIb/IIIa) receptor antagonistic activities were obtained by combining mimetics of the D-Phe-Pro-Arg pharmacophore of thrombin inhibitors and the Arg-Gly-Asp pharmacophore of GPIIb/IIIa receptor antagonists in the same low molecular weight peptidomimetic compound.. Systematic variation of the position of substituents around the 3,4-dihydro-2H-1,4-benzoxazine nucleus, the distance between the carboxylate and amidine moieties, together with additional substituents to fill the thrombin S2 and S3 pockets resulted in compounds displaying submicromolar inhibition constants (Ki) for thrombin and submicromolar IC50 for inhibition of binding of fibrinogen to platelet GPIIb/IIIa receptor.. Some of these compounds, such as 17a, 17b, 17d, and 17h possessing a well balanced activity at both targets, are a good starting point for further optimization. Article Title: High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis Article Snippet: .. The activities of coagulation factor II (FII:c), factor V (FV:c), and factor VIII (FVIII:c) in COVID-19 patients were measured on an ACL TOP 750 analyzer (Instrumentation Laboratory, Werfen), while in non-COVID-19 subjects from VHS the same parameters were assayed with a similar method on a Article Title: Platelet function testing in hirudin and BAPA anticoagulated blood Article Snippet: Background: Sodium citrate is the most commonly used anticoagulant for platelet function testing.. However, the use of citrated blood for platelet function analysis has been criticized due to creation of a non-physiological milieu.. Moreover, platelet function measurements performed with citrated blood need to be completed within 4 h after blood collection. Article Title: Coinheritance of three novel FV gene mutations in a patient with a severe FV deficiency. Article Snippet: V. BAFUNNO,* G. FAVUZZI , T. FIERRO, M. CHETTA,* E. MASTRODICASA,§ E. CHINNI, E. GRANDONE, M. MARGAGLIONE* and P. GRESELE *Medical Genetics, Department of Biomedical Sciences, University of Foggia, Foggia; Atherosclerosis and Thrombosis Unit, Research Department, Istituto di Ricovero e Cura a Carattere Scientifico, Casa Sollievo della Sofferenza, S. Giovanni Rotondo, Foggia; Department of Internal Medicine, Section of Internal and Cardiovascular Medicine, University of Perugia, Perugia; and §Pediatric Onco-Hematology, S. Maria della Misericordia Hospital, Perugia, Italy Article Title: Prothrombin complex concentrate (Beriplex P/N) for control of bleeding after kidney trauma in a rabbit dilutional coagulopathy model. Article Snippet: Abbreviations: CI, 95% confidence interval; FII, factor FX, factor X; HES, hydroxyethyl starch; IQR, interqua complex concentrate; PT, prothrombin time; rFVIIa, rec ☆ Presented in part at the 53rd Annual Meeting of th Hemostasis Research, Vienna, Austria, February 4-7, 200 ⁎ Corresponding author.. Senior Director of Preclinica CSL Behring GmbH, Emil von Behring-Straße 76, D-3504 6421 39 2306; fax: +49 6421 39 5310.. E-mail address: gerhard.dickneite@cslbehring.com ( Article Title: Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele Article Snippet: .. FII:c, FV:c, and FVIII:c were measured on a Article Title: High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis. Article Snippet: .. The activities of coagulation factor II (FII:c), factor V (FV:c), and factor VIII (FVIII:c) in COVID-19 patients were measured on an ACL TOP 750 analyzer (Instrumentation Laboratory, Werfen), while in non-COVID-19 subjects from VHS the same parameters were assayed with a similar method on a Incubation:Article Title: 3,4-Dihydro-2H-1,4-benzoxazine derivatives combining thrombin inhibitory and glycoprotein IIb/IIIa receptor antagonistic activity as a novel class of antithrombotic compounds with dual function. Article Snippet: 3,4-Dihydro-2H-1,4-benzoxazine derivatives possessing both thrombin inhibitory and glycoprotein IIb/IIIa (GPIIb/IIIa) receptor antagonistic activities were obtained by combining mimetics of the D-Phe-Pro-Arg pharmacophore of thrombin inhibitors and the Arg-Gly-Asp pharmacophore of GPIIb/IIIa receptor antagonists in the same low molecular weight peptidomimetic compound.. Systematic variation of the position of substituents around the 3,4-dihydro-2H-1,4-benzoxazine nucleus, the distance between the carboxylate and amidine moieties, together with additional substituents to fill the thrombin S2 and S3 pockets resulted in compounds displaying submicromolar inhibition constants (Ki) for thrombin and submicromolar IC50 for inhibition of binding of fibrinogen to platelet GPIIb/IIIa receptor.. Some of these compounds, such as 17a, 17b, 17d, and 17h possessing a well balanced activity at both targets, are a good starting point for further optimization. Concentration Assay:Article Title: 3,4-Dihydro-2H-1,4-benzoxazine derivatives combining thrombin inhibitory and glycoprotein IIb/IIIa receptor antagonistic activity as a novel class of antithrombotic compounds with dual function. Article Snippet: 3,4-Dihydro-2H-1,4-benzoxazine derivatives possessing both thrombin inhibitory and glycoprotein IIb/IIIa (GPIIb/IIIa) receptor antagonistic activities were obtained by combining mimetics of the D-Phe-Pro-Arg pharmacophore of thrombin inhibitors and the Arg-Gly-Asp pharmacophore of GPIIb/IIIa receptor antagonists in the same low molecular weight peptidomimetic compound.. Systematic variation of the position of substituents around the 3,4-dihydro-2H-1,4-benzoxazine nucleus, the distance between the carboxylate and amidine moieties, together with additional substituents to fill the thrombin S2 and S3 pockets resulted in compounds displaying submicromolar inhibition constants (Ki) for thrombin and submicromolar IC50 for inhibition of binding of fibrinogen to platelet GPIIb/IIIa receptor.. Some of these compounds, such as 17a, 17b, 17d, and 17h possessing a well balanced activity at both targets, are a good starting point for further optimization. Modification:Article Title: High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis Article Snippet: .. The activities of coagulation factor II (FII:c), factor V (FV:c), and factor VIII (FVIII:c) in COVID-19 patients were measured on an ACL TOP 750 analyzer (Instrumentation Laboratory, Werfen), while in non-COVID-19 subjects from VHS the same parameters were assayed with a similar method on a Article Title: Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele Article Snippet: .. FII:c, FV:c, and FVIII:c were measured on a Article Title: High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis. Article Snippet: .. The activities of coagulation factor II (FII:c), factor V (FV:c), and factor VIII (FVIII:c) in COVID-19 patients were measured on an ACL TOP 750 analyzer (Instrumentation Laboratory, Werfen), while in non-COVID-19 subjects from VHS the same parameters were assayed with a similar method on a |